Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD

• Main Authors: Paolo Montuschi (Author), Giuseppe Santini (Author), Nadia Mores (Author), Alessia Vignoli (Author), Francesco Macagno (Author), Rugia Shoreh (Author), Leonardo Tenori (Author), Gina Zini (Author), Leonello Fuso (Author), Chiara Mondino (Author), Corrado Di Natale (Author), Arnaldo D'Amico (Author), Claudio Luchinat (Author), Peter J. Barnes (Author), Tim Higenbottam (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Prospective pharmacological studies on breathomics profiles in COPD patients have not been previously reported. We assessed the effects of treatment and withdrawal of an extrafine inhaled corticosteroid (ICS)-long-acting β2-agonist (LABA) fixed dose combination (FDC) using a multidimensi...